Search Results for: SRPK2

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
HMGXB4 HMG-box containing 4
HNRNPA1 heterogeneous nuclear ribonucleoprotein A1
  • FGFR2 alternative splicing
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
HNRNPA3 heterogeneous nuclear ribonucleoprotein A3
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
HNRNPC heterogeneous nuclear ribonucleoprotein C
  • SUMOylation of RNA binding proteins
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
HNRNPK heterogeneous nuclear ribonucleoprotein K
  • SUMOylation of RNA binding proteins
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
  • HCMV Late Events
  • Artenimol
  • Phenethyl Isothiocyanate
HOMER3 homer scaffold protein 3
  • Neurexins and neuroligins
  • Neurexins and neuroligins
HOXB6 homeobox B6
HTATSF1 HIV-1 Tat specific factor 1
IFIT5 interferon induced protein with tetratricopeptide repeats 5
  • Interferon alpha/beta signaling
IRS2 insulin receptor substrate 2
  • PI3K Cascade
  • IRS-mediated signalling
  • SOS-mediated signalling
  • SOS-mediated signalling
  • PIP3 activates AKT signaling
  • Interleukin-7 signaling
  • PI3K/AKT activation
  • PI3K/AKT activation
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • IRS-related events triggered by IGF1R
  • Signaling by Leptin
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • IRS activation
  • Signal attenuation
  • RET signaling
  • Signaling by Erythropoietin
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • Erythropoietin activates STAT5
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Growth hormone receptor signaling
ISLR immunoglobulin superfamily containing leucine rich repeat
  • Platelet degranulation
JMJD1C jumonji domain containing 1C
  • Factors involved in megakaryocyte development and platelet production
KANK2 KN motif and ankyrin repeat domains 2
KCNN2 potassium calcium-activated channel subfamily N member 2
  • Ca2+ activated K+ channels
  • Procaine
  • Miconazole
  • Trimebutine
KHDRBS1 KH RNA binding domain containing, signal transduction associated 1
  • PTK6 Regulates Proteins Involved in RNA Processing
KIF11 kinesin family member 11
  • MHC class II antigen presentation
  • COPI-dependent Golgi-to-ER retrograde traffic
  • Kinesins
  • 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol
  • Monastrol
  • Filanesib
  • (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE
  • N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE
  • (5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE
  • MK-0731
  • [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE
  • (2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE
  • (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE
  • (2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE
  • (5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE
KRT78 keratin 78
  • Keratinization
  • Formation of the cornified envelope
LBR lamin B receptor
  • Cholesterol biosynthesis
  • Initiation of Nuclear Envelope (NE) Reformation
  • Regulation of MECP2 expression and activity
  • HEM skeletal dysplasia; Greenberg dysplasia
  • Pelger-Huet anomaly
LCA5 lebercilin LCA5
  • Leber congenital amaurosis (LCR)
LCE3D late cornified envelope 3D
  • Formation of the cornified envelope

Page 9 out of 22 pages